Harvard Bioscience (HBIO) FCF Margin (2010 - 2026)
Harvard Bioscience's (HBIO) quarterly FCF Margin came in at 1.6% in Q2 2026, down 1463.0% year-over-year from 0.12% in Q2 2025, and up 69.53% quarter-over-quarter from 5.24% in Q1 2026.
Powered by 
Analysis
Harvard Bioscience (HBIO) FCF Margin (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported FCF Margin for 17 consecutive years, with 1.6% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin fell 1463.0% year-over-year to 1.6% in Q2 2026; TTM through Jun 2026 was 1.27%, a 673.0% decrease from a year earlier, with the FY2025 full-year figure at 6.32%, up 760.0% from the prior year.
- FCF Margin was 1.6% for Q2 2026 at Harvard Bioscience, up from 5.24% in the prior quarter.
- Over five years, FCF Margin peaked at 16.34% in Q3 2023 and troughed at 8.54% in Q1 2022.
- A 5-year average of 3.14% and a median of 3.68% in 2025 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin plunged 2418 bps in 2024 and surged 2024 bps in 2025, its largest moves.
- Over 5 years, FCF Margin stood at 8.6% in 2022, then surged by 43 bps to 12.34% in 2023, then slumped by 53 bps to 5.8% in 2024, then sank by 140 bps to 2.3% in 2025, then soared by 30 bps to 1.6% in 2026.
- The last three FCF Margin figures came in at 1.6% (Q2 2026), 5.24% (Q1 2026), and 2.3% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.04 Bn | 219.98 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 142.34 Bn | 137.99 Bn | 3.61 Bn | 20.19% |
| 3 | Agilent Technologies | 40.26 Bn | 38.50 Bn | 1.04 Bn | 23.38% |
| 4 | Illumina | 30.64 Bn | 29.47 Bn | 770.00 Mn | 13.89% |
| 5 | Revvity | 13.61 Bn | 12.59 Bn | 416.87 Mn | 24.79% |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | 27.07% |
| 7 | Bio-Rad Laboratories | 9.94 Bn | 8.32 Bn | 345.80 Mn | 10.25% |
| 8 | Repligen | 9.18 Bn | 8.17 Bn | 110.04 Mn | 13.44% |
| 9 | 10x Genomics | 8.69 Bn | 8.14 Bn | 112.50 Mn | 10.19% |
| 10 | Harvard Bioscience | 35.61 Mn | 29.11 Mn | 12.63 Mn | -1.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.60% |
| Mar 31, 2026 | -5.24% |
| Dec 31, 2025 | -2.30% |
| Sep 30, 2025 | 4.26% |
| Jun 30, 2025 | 13.04% |
| Mar 31, 2025 | 11.36% |
| Dec 31, 2024 | 5.80% |
| Sep 30, 2024 | -7.84% |
| Jun 30, 2024 | -7.20% |
| Mar 31, 2024 | 3.09% |
| Dec 31, 2023 | 12.34% |
| Sep 30, 2023 | 16.34% |
| Jun 30, 2023 | 10.55% |
| Mar 31, 2023 | 5.30% |
| Dec 31, 2022 | 8.60% |
| Sep 30, 2022 | 0.77% |
| Jun 30, 2022 | -2.16% |
| Mar 31, 2022 | -8.54% |
| Dec 31, 2021 | -0.73% |
| Sep 30, 2021 | -3.84% |